This study looks at how well mocravimod works for adults with acute myeloid leukemia (AML) who are getting a stem cell transplant. Researchers want to see if mocravimod can help patients stay in good health after the transplant. This is a phase 3 trial, meaning it focuses on how effective and safe the treatment is.
This is a Phase 3 trial, meaning it is looking at how well the treatment works and how safe it is. The trial is FDA-regulated and aims to include about 366 participants.
Who can join
Adults aged 18 to 75 with a diagnosis of AML can join. Patients must be planning to have a stem cell transplant. Those with certain health issues or who are using specific medications cannot participate. The trial team will confirm who is eligible.
Condition
Adult Acute Myeloid Leukemia
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be randomly placed into one of three groups: one group will take 3 mg of mocravimod daily, another group will take 1 mg of mocravimod daily, and the last group will receive a placebo (a look-alike pill with no medicine). Everyone will take their assigned treatment for 12 months.
Where
This trial is enrolling at 21 locations. Recruiting sites are listed first.
Baylor Charles A. Sammons Cancer Center
Dallas, Texas
Recruiting
City of Hope Comprehensive Cancer Center - Duarte
Duarte, California
Recruiting
Emory University - Winship Cancer Institute (WCI)
Atlanta, Georgia
Recruiting
Henry Ford Cancer Institute
Detroit, Michigan
Recruiting
Moffitt Cancer Center
Tampa, Florida
Recruiting
Oregon Health & Science University (OHSU) - Knight Cancer Institute
Portland, Oregon
Recruiting
The Ohio State University Comprehensive Cancer Center (OSUCCC)
Cleveland, Ohio
Recruiting
University of California Los Angeles (UCLA) - David Geffen School of Medicine
Elected to the National Academy of Medicine. Treats leukemia and myelodysplastic syndrome. The main doctor for adults with blood cancers, like leukemia, lymphoma, and myeloma. Recognized at state, national or international level.
Professor and transplant specialist, UC Davis. Treats leukemia, lymphoma and multiple myeloma. The main doctor for adults with blood cancers, like leukemia, lymphoma, and myeloma. Recognized at state, national or international level.